This compound is primarily used in the pharmaceutical and agrochemical industries as a key intermediate in the synthesis of more complex molecules. Its boronic acid group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to form carbon-carbon bonds in the production of drugs and other bioactive compounds. The trifluoromethyl group enhances the lipophilicity and metabolic stability of the resulting molecules, making it particularly useful in designing compounds with improved pharmacokinetic properties. Additionally, the deuterated methoxy group can be leveraged in studies involving isotopic labeling, aiding in drug metabolism research and the development of deuterated drugs for enhanced efficacy and safety.